With the development of methodologies for the manufacture of human gro
wth hormone in essentially unlimited quantities, the capability now ex
ists for treatment of a wide variety of growth disorders besides growt
h hormone deficiency. It is, consequently, all the more important that
a rational basis be developed for the evaluation of children with gro
wth failure so that diagnostic and therapeutic strategies can be based
on sound and logical medical practice.